Clinical trial
Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in…
NCT00186745 · St. Joseph's Healthcare Hamilton, Other · Terminated
Key facts
| NCT number | NCT00186745 |
|---|---|
| Title | Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure |
| Official title | Tinzaparin for Treatment of Venous Thromboembolism in Renal Insufficiency: A Pilot Study |
| Lead sponsor | St. Joseph's Healthcare Hamilton, Other |
| Collaborators | Heart and Stroke Foundation of Ontario LEO Pharma Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Venous Thrombosis, Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | Tinzaparin |
| Enrollment | 148 |
| Start date | Mar 1, 2005 |
| Primary completion | Nov 1, 2015 |
| Completion | Feb 1, 2016 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 19, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: